Pharmaceutical

Civica to Build an Essential Medicines Manufacturing Facility in Virginia

General Health, Pharmaceutical, Health, Other Health, Natural sciences, Civica Rx, Chemistry, Civica, Essential medicines, Fine chemical, Life sciences
Thursday, January 21, 2021 - 6:04pm

Civica Rx (Civica, Inc.) today announced, along with Virginias Governor Ralph Northam , its plans to build a 120,000 square-foot sterile injectable manufacturing facility in Petersburg, Virginia, potentially creating more than 180 jobs.

Key Points: 
  • Civica Rx (Civica, Inc.) today announced, along with Virginias Governor Ralph Northam , its plans to build a 120,000 square-foot sterile injectable manufacturing facility in Petersburg, Virginia, potentially creating more than 180 jobs.
  • This is a dream come true for Civica and our hospital partners as we continue to work together to stabilize the supply of essential medicines for patients across the country, said Martin VanTrieste, President and CEO of Civica.
  • Civica is a key collaborator in the U.S. government-funded partnership with Phlow Corp., Medicines for All Institute at Virginia Commonwealth University and AMPAC Fine Chemicals, which is also located in Petersburg.
  • The company will manufacture precursor chemical ingredients, active pharmaceutical ingredients (API), and finished pharmaceutical products, domestically for essential medicines critical to the Nations healthcare.

ProvideGx® Partners with Pfizer Inc. to Secure the Supply of Five Essential Medications

Health, Hospitals, Practice Management, Other Health, Managed care, General Health, Pharmaceutical, Nervous system, Branches of biology, Anesthesia, Acute pain, Anilides, Citrates, Fentanyl, Injection, Surgery, Pain, Lethal injection, Opioid epidemic in the United States
Thursday, January 21, 2021 - 6:00pm

Fentanyl is a controlled substance used to prevent pain for short periods of time, usually before anesthesia is administered or immediately after surgical procedures.

Key Points: 
  • Fentanyl is a controlled substance used to prevent pain for short periods of time, usually before anesthesia is administered or immediately after surgical procedures.
  • The 0.9 percent sodium chloride injection is used to dilute other medications before injection.
  • These five medications are critical for patient care and in some cases are necessary as part of COVID-19 treatments.
  • Our partnership with Pfizer will help ensure a sustainable supply of five drugs that are essential not just during the pandemic, but also for routine and elective care longer term.

SCIEX Acquires Intabio, a developer of precision solutions for biotherapeutic analysis through imaged cIEF-MS

Software, Research, General Health, Pharmaceutical, Electronic design automation, Technology, Science, Nanotechnology, Biotechnology, Other Technology, Other Science, Health, Science and technology, Clinical pathology, Mass spectrometry, Spectrometers, Science, Scientific method
Thursday, January 21, 2021 - 5:00pm

Blaze enables the direct coupling of imaged cIEF charge variant analysis with high-resolution mass spectrometry to detect intact proteins.

Key Points: 
  • Blaze enables the direct coupling of imaged cIEF charge variant analysis with high-resolution mass spectrometry to detect intact proteins.
  • Imaged cIEF-MS technology provides a groundbreaking solution for those looking for better and faster tools to characterize their increasingly complex biomolecules.
  • The Blaze System coupled to high-resolution mass spectrometry provides a streamlined approach that can reduce lengthy sample prep and deliver increased sample throughput.
  • SCIEX delivers solutions for the precision detection and quantification of molecules, empowering our customers to protect and advance the wellness and safety of all.

COVID-19 Impacts and Recovery | Global Hepatitis C Drugs Market Research During 2021-2025 | Technavio

Infectious diseases, Pharmaceutical, Health, Hepatitis
Thursday, January 21, 2021 - 4:50pm

View the full release here: https://www.businesswire.com/news/home/20210121005731/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210121005731/en/
    Technavio has announced its latest market research report titled Global Hepatitis C Drugs Market 2021-2025 (Graphic: Business Wire).
  • The report on the hepatitis C drugs market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
  • The hepatitis C drugs market analysis includes the product and geography landscape.
  • The hepatitis C drugs market covers the following areas:

Lundbeck Recognized as One of the Best Companies to Work for in Egypt

Health, Professional services, Other Professional Services, Pharmaceutical, Human resources, Countries, Continents, Geography of Africa, Lundbeck, Valby, Egypt
Thursday, January 21, 2021 - 4:35pm

In 2015, we set out to realize a dream; 'To establish Lundbeck Egypt among the best employers in the pharmaceutical industry through a unique culture and working environment'.

Key Points: 
  • In 2015, we set out to realize a dream; 'To establish Lundbeck Egypt among the best employers in the pharmaceutical industry through a unique culture and working environment'.
  • We will continue to strive to make Lundbeck Egypt an even better place to work, so we can continue to make a difference for people living with brain diseases said Ahmed El-Ashmawy, Country Manager for Lundbeck Egypt.
  • "Despite the disruption brought about by the pandemic, the results showed that Lundbeck employees in Egypt feel overwhelmingly positive toward the workplace culture said Hamza Idrissi, Program Manager for Egypt.
  • Best Places To Work is the most definitive Employer of Choice certification that organizations aspire to achieve.

The Vistria Group and Excellere Partners Invest in SCA Pharmaceuticals

Medical Supplies, Infectious diseases, Hospitals, Finance, FDA, Professional services, Cardiology, Biotechnology, Pharmaceutical, Health, SCA, Pharmaceutical industry in China
Thursday, January 21, 2021 - 4:59pm

The Vistria Group and Excellere Partners have purchased all of the issued and outstanding equity interests of SCA Pharma.

Key Points: 
  • The Vistria Group and Excellere Partners have purchased all of the issued and outstanding equity interests of SCA Pharma.
  • We are very pleased that as we continue our expansion efforts and improvements in our efficiencies, our new partnership with The Vistria Group and Excellere will allow us to accelerate these efforts, said Milton Boyer, CEO of SCA Pharma.
  • We look forward to working with Excellere to take the high standards set by SCA even further, said Jon Maschmeyer, Partner at Vistria.
  • An emerging national leader in compounded pharmaceuticals, SCA Pharma previously was wholly owned by Enhanced Healthcare Partners.

Folding Carton in Healthcare Market - Global Growth, Trends, and Forecasts to 2025: Digital Printing will Hold the Largest Market Share - ResearchAndMarkets.com

Packaging, Pharmaceutical, Health, Manufacturing, Packaging, Containers, Folding carton, Carton
Thursday, January 21, 2021 - 4:09pm

The "Folding Carton in Healthcare Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Folding Carton in Healthcare Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.
  • The Folding carton market for the Healthcare market is expected to register a CAGR of 4.12% during this forecast period.
  • However, the major vendors in this market also provide customized folded carton packaging solutions for its customers.
  • Additionally, in 2019 Unipak, Inc offered a digitally printed folding carton solution for MediNatura, a leader in homeopathic pain relief.

Rite Aid Expands No-Charge COVID-19 Testing to 460 Drive-Through Locations

Other Consumer, Discount, Variety, Infectious diseases, Convenience store, Other Health, Health, Consumer, Pharmaceutical, Retail, Rite Aid, COVID-19 testing, Medicine, Health care, Companies
Thursday, January 21, 2021 - 3:00pm

The new locations will increase Rite Aid's capacity for COVID-19 testing services in California, Washington, Michigan, Ohio, Pennsylvania, Virginia, New York, Massachusetts, New Jersey and Maryland.

Key Points: 
  • The new locations will increase Rite Aid's capacity for COVID-19 testing services in California, Washington, Michigan, Ohio, Pennsylvania, Virginia, New York, Massachusetts, New Jersey and Maryland.
  • At all testing locations, patients are required to pre-register online at www.riteaid.com in order to schedule a time slot for testing.
  • Rite Aid partners with Verily and its Baseline COVID-19 Testing Program to provide screening, scheduling and return of results to participants for Rite Aid testing sites.
  • Rite Aid will continue to provide regular updates on the company's progress with COVID-19 testing.

Beacon Health Options Provides Needed Relief for Those Caught in Twin Pandemics of Opioid Use Disorder and COVID-19

Mental health, MEN, Managed care, Professional services, Infectious diseases, Gay & Lesbian, Hospitals, Family, Consumer, Health, Other Health, Other Consumer, Insurance, Teens, Women, Parenting, Pharmaceutical, Opioid use disorder, Substance dependence, Beacon Health Options, Opioid, Opioid epidemic in the United States
Thursday, January 21, 2021 - 2:50pm

The crisis of increasing opioid use disorder (OUD) shows no sign of abating in Massachusetts.

Key Points: 
  • The crisis of increasing opioid use disorder (OUD) shows no sign of abating in Massachusetts.
  • Clearly, more needs to be done to save lives that are being taken prematurely by opioid use disorder.
  • In late 2019, to help address this ongoing crisis in Massachusetts, Beacon Health Options, a leading behavioral health services company headquartered in Boston, announced the distribution of $128,800 in grants to four community-based behavioral health organizations.
  • Beacon Health Options is a leading behavioral health services company serving 1 out of 9 people across all 50 states.

2021 Global IgA Nephropathy Clinical Trial Pipeline Highlights - ResearchAndMarkets.com

Pharmaceutical, Health, Clinical trials, Health sciences, Health, Clinical research, Drug discovery, Pharmaceutical industry, Kidney diseases, Design of experiments, Clinical trial, IgA nephropathy, Diabetic nephropathy, Blisibimod
Thursday, January 21, 2021 - 2:44pm

The "Global IgA Nephropathy Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global IgA Nephropathy Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.
  • This report provides the most up-to-date information on key pipeline products in the global IgA Nephropathy market.
  • It covers emerging therapies for IgA Nephropathy in active clinical development stages including early and late stage clinical trials.
  • The report provides IgA Nephropathy pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.